10 February 2020

2020 European Meeting of ISMPP
Precision communication: achieving clarity, reach and value
21–22 January 2020, London, UK

In January 2020 over 350 medical publication professionals from across industry, publishers and agencies came together in London to attend the European meeting of ISMPP; we were there as a 10-strong team to experience first hand the engaging programme on offer. We were also lucky enough to have six posters accepted, including two oral poster presentations; several of these posters were the outcome of collaborations with our clients in Takeda, Novartis and Ipsen.

Continue reading

30 January 2020

Oxford PharmaGenesis presents at CBI's 7th Annual Clinical Data Disclosure, Transparency & Plain Language Summaries Conference

During a busy week for Oxford PharmaGenesis, a successful Open Pharma roundtable and ISMPP EU conference were followed by a plenary presentation at the opening session of CBI’s 7th Annual Clinical Data Disclosure, Transparency & Plain Language Summaries Conference in Miami, FL, USA (22–24 January 2020).

Continue reading

23 December 2019

Evidence Aid is our charity of the year!

Oxford PharmaGenesis is proud to announce that its annual charity donation is being made to Evidence Aid, an Oxford-based global charity that champions evidence-based humanitarian action in places threatened by disaster.

Continue reading

5 December 2019

Catching up on the state of publications at ISMPP West 2019

Oxford PharmaGenesis was delighted to attend the West Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 14 and 15 November 2019 in San Diego, CA, USA.

Continue reading

2 December 2019

Oxford PharmaGenesis Arrives in Cambridge

Continued growth has led Oxford PharmaGenesis, the leading HealthScience communications consultancy, to create a new UK office in Cambridge.

Continue reading

26 November 2019

Oxford PharmaGenesis at World Orphan Drug Congress 2019

In mid-November Barcelona played host to the World Orphan Drug Congress 2019, Europe’s largest commercially focused conference for the rare disease community. Representatives from Oxford PharmaGenesis were in attendance over the 3-day meeting. The conference was broad-ranging in terms of sessions and speakers; however, there were some sessions of particular note.

Continue reading
1 2 3 4 28